AstraZeneca/LinkedIn
Jun 9, 2025, 19:32
AstraZeneca – What Could Happen When Policy Interventions Focus on Improved Detection and Treatment of CKD?
AstraZeneca shared on LinkedIn:
“What could happen when policy interventions focus on improved detection and treatment of chronic kidney disease (CKD)?
Modelling across eight countries predicts these measures can help people with CKD live healthier lives, while supporting long-term economic productivity and workforce participation.
Explore the evidence on the Make the Change For Kidney Health website.”
AstraZeneca shared modeling projections from eight countries showing that policy efforts aimed at better detection and treatment of chronic kidney disease (CKD) can enhance patient outcomes and promote economic productivity.
Find More Posts Featuring AstraZeneca on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 11, 2025, 19:36
Aug 11, 2025, 19:28
Aug 11, 2025, 19:13
Aug 11, 2025, 19:08
Aug 11, 2025, 19:01
Aug 11, 2025, 18:54
Aug 11, 2025, 18:46
Aug 11, 2025, 18:42